Showing results (1-10 of 436) with videos related to
Sort By:
Pageof 44
Expert Opinion on Drug Safety|August 24, 2014
Safety of ACE inhibitor therapies in patients with chronic kidney diseaseGrigory Sidorenkov, Gerjan NavisCurrent Opinion in Nephrology and Hypertension|September 16, 2014
Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney diseaseJelmer K Humalda, Gerjan NavisCurrent Hypertension Reports|October 4, 2011
Improvement of sodium status to optimize the efficacy of Renin-Angiotensin system blockadeGozewijn D Laverman, Gerjan NavisPharmacological Research|April 5, 2016
Sodium intake, RAAS-blockade and progressive renal diseaseMartin H de Borst, Gerjan NavisNature Clinical Practice. Nephrology|October 8, 2008
Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal diseasePaul E de Jong, Gerjan NavisJournal of the American Society of Nephrology : JASN|December 6, 2002
Renoprotection: a matter of blood pressure reduction or agent-characteristics?Liffert Vogt, Gerjan Navis, Dick de ZeeuwJournal of the American Society of Nephrology : JASN|June 7, 2005
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?Liffert Vogt, Gerjan Navis, Dick de ZeeuwKidney & Blood Pressure Research|November 20, 2008
Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in ratsFemke Waanders, Harry van Goor, Gerjan NavisJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 14, 2003
Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?Gozewijn D Laverman, Dick de Zeeuw, Gerjan NavisCurrent Opinion in Nephrology and Hypertension|August 29, 2009
Benefits of dietary sodium restriction in the management of chronic kidney diseaseJan A Krikken, Gozewijn D Laverman, Gerjan NavisPageof 44